Lumentum (NASDAQ:LITE - Get Free Report) posted its earnings results on Tuesday. The technology company reported $2.37 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.13, FiscalAI reports. Lumentum had a return on equity of 17.27% and a net margin of 11.95%.The business had revenue of $808.40 million for the quarter, compared to analysts' expectations of $810.05 million. During the same quarter in the previous year, the firm earned $0.57 earnings per share. The business's revenue was up 90.1% compared to the same quarter last year. Lumentum updated its Q4 2026 guidance to 2.850-3.050 EPS.
Here are the key takeaways from Lumentum's conference call:
- Lumentum delivered a record quarter with $808 million revenue (+90% YoY) and a strong non‑GAAP operating margin of 32.2%, driven by transceivers and laser chips.
- The company is materially supply‑constrained — EMLs, pump lasers and narrow‑linewidth lasers are effectively sold out with a supply‑demand gap >30%, forcing allocation choices that cap near‑term shipments.
- Q4 guidance targets another record (revenue $960M–$1.01B, midpoint $985M) and 35%–36% non‑GAAP operating margin, with transceiver ramps (including 1.6T and partial insourcing of CW lasers) expected to drive the bulk of sequential growth.
- Lumentum is investing in long‑term capacity (acquired Greensboro InP fab, CPO/ultra‑high‑power laser ramps and multi‑rail/scale‑across products) that should expand margins and address demand, but Greensboro capacity won’t materially contribute until 2028.
Lumentum Stock Performance
LITE stock traded up $18.38 during trading on Tuesday, hitting $994.56. The company had a trading volume of 6,328,268 shares, compared to its average volume of 5,510,206. The firm has a market cap of $71.01 billion, a PE ratio of 524.83 and a beta of 1.53. Lumentum has a 1-year low of $60.38 and a 1-year high of $1,021.00. The firm has a 50-day moving average price of $760.12 and a 200-day moving average price of $486.41. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 0.06.
Key Stories Impacting Lumentum
Here are the key news stories impacting Lumentum this week:
- Positive Sentiment: Q3 EPS beat — Lumentum reported $2.37 EPS vs. the Zacks/consensus $2.24, showing continued margin leverage and earnings momentum. Lumentum (LITE) Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Raised FY‑quarter guidance — management updated Q4 2026 EPS guidance to $2.85–$3.05 vs. consensus $2.59, signaling better-than-expected near-term profitability and giving investors clearer upside visibility.
- Positive Sentiment: Analyst upgrades — Stifel raised its price target to $1,100 (buy) and Loop Capital to $1,400 (buy), bringing additional buy-side endorsement that can support further upside. Stifel raises PT Loop Capital raises PT
- Positive Sentiment: High-profile bullish commentary — Jim Cramer publicly said he would buy Lumentum, which can attract momentum flows and retail interest ahead of/after earnings. Jim Cramer Shows Bullish Sentiment
- Neutral Sentiment: Revenue roughly in line — Q3 revenue was $808.4M versus consensus ~$810.1M, a very small miss that tempers but doesn’t negate the EPS beat; see the company release/slide deck for line-item detail. Press Release / Slide Deck
- Neutral Sentiment: Heavy media and momentum flow — broad coverage and massive YTD gains amplify trading interest and volume; that can extend moves but also increases short-term volatility. Does Lumentum’s 1,444% Surge Come to an End?
- Negative Sentiment: Valuation and pullback risk — the stock’s rapid multi‑hundred‑percent rise and high reported P/E leave it exposed to profit‑taking if growth or execution stumbles; investors should weigh earnings momentum against elevated valuation.
Insider Buying and Selling
In other Lumentum news, insider Vincent Retort sold 45,026 shares of Lumentum stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $591.32, for a total value of $26,624,774.32. Following the sale, the insider owned 102,455 shares of the company's stock, valued at approximately $60,583,690.60. The trade was a 30.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Yuen Wupen sold 3,157 shares of Lumentum stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $538.00, for a total value of $1,698,466.00. Following the completion of the sale, the insider directly owned 88,439 shares in the company, valued at $47,580,182. This represents a 3.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 65,775 shares of company stock worth $38,851,343. Insiders own 0.43% of the company's stock.
Institutional Investors Weigh In On Lumentum
A number of institutional investors have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership boosted its stake in shares of Lumentum by 8,579.2% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,563,210 shares of the technology company's stock worth $254,350,000 after acquiring an additional 1,545,199 shares in the last quarter. Value Aligned Research Advisors LLC purchased a new stake in shares of Lumentum during the 4th quarter worth approximately $432,062,000. Voloridge Investment Management LLC boosted its stake in shares of Lumentum by 107.5% during the 3rd quarter. Voloridge Investment Management LLC now owns 644,194 shares of the technology company's stock worth $104,817,000 after acquiring an additional 333,734 shares in the last quarter. Freestone Grove Partners LP boosted its stake in shares of Lumentum by 809.5% during the 3rd quarter. Freestone Grove Partners LP now owns 261,224 shares of the technology company's stock worth $42,504,000 after acquiring an additional 232,503 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Lumentum by 66.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 499,612 shares of the technology company's stock worth $184,153,000 after acquiring an additional 199,726 shares in the last quarter. Hedge funds and other institutional investors own 94.05% of the company's stock.
Wall Street Analyst Weigh In
LITE has been the topic of a number of research analyst reports. TD Cowen lifted their target price on Lumentum from $675.00 to $875.00 and gave the stock a "hold" rating in a research report on Friday, April 10th. JPMorgan Chase & Co. lifted their target price on Lumentum to $950.00 and gave the stock an "overweight" rating in a research report on Thursday, April 9th. Barclays lifted their target price on Lumentum to $750.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 3rd. Susquehanna lifted their target price on Lumentum from $550.00 to $1,100.00 and gave the stock a "positive" rating in a research report on Monday, April 20th. Finally, Needham & Company LLC lifted their target price on Lumentum from $880.00 to $1,040.00 and gave the stock a "buy" rating in a research report on Tuesday, April 21st. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $812.71.
Check Out Our Latest Stock Report on Lumentum
About Lumentum
(
Get Free Report)
Lumentum Holdings Inc, headquartered in San Jose, California, is a leading provider of photonic technologies that enable high-speed optical communication networks and advanced industrial applications. The company designs and manufactures a broad range of lasers, optical modules and subsystems tailored to the evolving requirements of telecommunications carriers, cloud data centers and enterprise networking.
Its core product portfolio includes tunable and fixed-wavelength laser transmitters, coherent optical engines, transceivers for long-haul, metro and data center interconnects, as well as test and measurement instruments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lumentum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumentum wasn't on the list.
While Lumentum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report